Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04830137
Title A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nurix Therapeutics, Inc.

mantle cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

marginal zone B-cell lymphoma

chronic lymphocytic leukemia

B-cell lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

Waldenstroem's macroglobulinemia



Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Recruiting Duarte California 91010 United States Details
University of California Irvine Recruiting Orange California 92868 United States Details
University of California San Francisco Medical Center Recruiting San Francisco California 94143 United States Details
Sarah Cannon Research Institute at Colorado Blood Cancer Institute Recruiting Denver Colorado 80218 United States Details
Sarah Cannon Research Institute at Florida Cancer Specialists Recruiting Sarasota Florida 34203 United States Details
National Institutes of Health Clinical Center Recruiting Bethesda Maryland 20814 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
University of Cincinnati Medical Center Recruiting Cincinnati Ohio 45267 United States Details
OSU Wexner Medical Center Recruiting Columbus Ohio 43210 United States Details
Sarah Cannon Research Institute at Tennessee Oncology Recruiting Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
Swedish Cancer Institute Recruiting Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from for the field